相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK
Julius G. Juarez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment
J. Juarez et al.
LEUKEMIA (2007)
Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype
Sergej Konoplev et al.
CANCER (2007)
CXCR4 is a prognostic marker in acute myelogenous leukemia
Anke C. Spoo et al.
BLOOD (2007)
Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies
BM Woerner et al.
CANCER RESEARCH (2005)
The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer
H Kang et al.
BREAST (2005)
Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia
S Konoplev et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow
N Cabioglu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
PML-RARα is associated with leptin-receptor induction:: the role of mesenchymal stem cell-derived adipocytes in APL cell survival
Y Tabe et al.
BLOOD (2004)
Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia
EJC Rombouts et al.
BLOOD (2004)
CXCR4 regulates growth of both primary and metastatic breast cancer
MCP Smith et al.
CANCER RESEARCH (2004)
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
JB Rubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The biology and therapy of adult acute lymphoblastic leukemia
S Faderl et al.
CANCER (2003)
The bicyclam AMD3 100 story
E De Clercq
NATURE REVIEWS DRUG DISCOVERY (2003)
β-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation
Y Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Is high expression of the chemokine receptor CXCR-4 of predictive value for early relapse in childhood acute lymphoblastic leukaemia?
P Schneider et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
S Hatse et al.
FEBS LETTERS (2002)
High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia
R Crazzolara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers
CW Hendrix et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers
KF Bradstock et al.
LEUKEMIA (2000)
β-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between β-arrestin and CXCR4
ZJ Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
